Istituto Tumori Bari Giovanni Paolo II - IRCCS
Bari 70124
1 studies enrolling now · 2 studies all time
What they study most
Advanced Non-Small Cell Lung Cancer, Locally Advanced or Metastatic Unresectable Urothelial Cancer, Metastatic Non-Small Cell Lung Cancer
Studies at this site
- Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
- Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Completed